Back
Roivant Sciences Quote, Financials, Valuation and Earnings
Sponsored
ROIV
Sponsored
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
34
ROIV
Roivant Sciences
Last Price:
11.13
Seasonality Move:
19.8%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.Roivant Sciences Price Quote
$11.13
-0.07 (-0.63%)
(Updated: November 18, 2024 at 9:45 AM ET)
Roivant Sciences Key Stats
Sell
34
Roivant Sciences (ROIV)
is a Sell
Day range:
$11.14 - $11.61
52-week range:
$8.56 - $13.06
Dividend yield:
0%
P/E ratio:
2.23
P/S ratio:
59.70
P/B ratio:
1.58%
Volume:
8.4M
Avg. volume:
4.2M
1-year change:
23.48%
Market cap:
$8.6B
Revenue:
$124.8M
EPS:
$5.56
How Much Does Roivant Sciences Make?
-
How Much Are Roivant Sciences's Sales Annually?
ROIV Revenues are $124.8M -
How Much Profit Does Roivant Sciences's Make A Year?
ROIV net income is $4.3B
Is Roivant Sciences Growing As A Company?
-
What Is Roivant Sciences's Growth Rate Quarterly?
Quarterly YoY revenue growth is 1.55% -
What Is Roivant Sciences's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Roivant Sciences Stock Price Performance
-
Did Roivant Sciences Stock Go Up Last Month?
Roivant Sciences share price went down by -5.72% last month -
Did ROIV's Share Price Rise Over The Last Year?
ROIV share price rose by 23.48% over the past 1 year
What Is Roivant Sciences 52-Week High & Low?
-
What Is Roivant Sciences’s 52-Week High Share Price?
Roivant Sciences has traded as high as $13.06 over the past 52 weeks -
What Is Roivant Sciences’s 52-Week Low Share Price?
Roivant Sciences has traded as low as $8.56 over the past 52 weeks
Roivant Sciences Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Roivant Sciences?
-
How Much Debt Does Roivant Sciences Have?
Total long term debt quarterly is $323.7M -
How Much Cash Does Roivant Sciences Have?
Cash and short term investments quarterly total is $5.7B -
What Is Roivant Sciences’s Book Value Per Share?
Book value per share is 7.35
Is Roivant Sciences Cash Flow Positive?
-
What Is ROIV Cash Flow From Operations?
Cash flow from operations (TTM) is -$708.2M -
What Is Roivant Sciences’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$248.7M -
What Is Roivant Sciences’s Cash Flow From Investing?
Cash flow from investing (TTM) is $5.2B
Roivant Sciences Return On Invested Capital
-
Is Management Doing A Good Job?
ROIV return on invested capital is 100.04% -
What Is Roivant Sciences Return On Assets?
ROA measures how assets are converting to revenues and is 93.84% -
What Is ROIV Return On Equity?
ROE is a measure of profitability and is 109.69%
Roivant Sciences Earnings Date & Stock Price
-
What Is Roivant Sciences's Stock Price Today?
A single share of ROIV can be purchased today for 11.20 -
What Is Roivant Sciences’s Stock Symbol?
Roivant Sciences trades on the nasdaq under the ticker symbol: ROIV -
When Is Roivant Sciences’s Next Earnings Date?
The next quarterly earnings date for Roivant Sciences is scheduled on February 13, 2025 -
When Is ROIV's next ex-dividend date?
Roivant Sciences's next ex-dividend date is November 18, 2024 -
How To Buy Roivant Sciences Stock?
You can buy Roivant Sciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Roivant Sciences Competitors
-
Who Are Roivant Sciences's Competitors?
Below is a list of companies who compete with Roivant Sciences or are related in some way:
Roivant Sciences Dividend Yield
-
What Is ROIV Dividend Yield?
Roivant Sciences’s dividend yield currently is 0% -
What Is Roivant Sciences’s Payout Ratio?
Roivant Sciences’s payout ratio is 0% -
When Did Roivant Sciences Last Pay A Dividend?
The latest dividend pay date is November 18, 2024 -
What Is Roivant Sciences’s Dividend Per Share?
Roivant Sciences pays a dividend of $0.00 per share
Roivant Sciences Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -56.32% |
Revenue: | 154.96% | -43.14% |
Analyst Recommendations
Buy Recommendations: | 6 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 15.92 |
Upside from Last Price: | 42.11% |